Hers vs IVY RX: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Hers starts at $199/mo and IVY RX at $197/mo. Hers scores higher on our ClearScore (79 vs 69), and IVY RX is the cheaper starting option.
Quick Verdict
Hers has the higher ClearScore (79 vs 69)
IVY RX is more affordable ($197/mo vs $199/mo)
Hers has higher ratings (4.5/5 vs 3.8/5)
IVY RX scores better on value (4.3/5 vs 4.2/5)
Hers
$199/mo
starting price
Women-focused GLP-1 program with tailored support, great app, and content designed for women's health needs.
IVY RX
$197/mo
starting price
Flat-rate GLP-1 pricing that does not increase with dose. Semaglutide from $175/mo. Pharmacist-founded, 200K+ members.
Hers vs IVY RX: Full Comparison
| Hers | IVY RX | |
|---|---|---|
| ClearScore | 79/100 ✓ | 69/100 |
| Overall Rating | 4.5/5 ✓ | 3.8/5 |
| Review Count | 156 ✓ | 67 |
| Starting Price | $199/mo | $197/mo ✓ |
| Medications | Compounded Semaglutide | Compounded Semaglutide, Compounded Tirzepatide ✓ |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Not accepted |
| HSA/FSA | Accepted | Accepted |
| Founded | 2019 | 2023 |
| States Served | All 50 states | All 50 states |
Programs & Pricing
Hers Programs
GLP-1 Weight Loss
$199/mo
Medications: Compounded Semaglutide
- Medication
- Clinician Support
- Progress Tracking
- Free Shipping
IVY RX Programs
Semaglutide Program
$175-197/mo
Medications: Compounded Semaglutide
- Medication
- Consultation
- Shipping
- Supplies
Tirzepatide Program
$275-297/mo
Medications: Compounded Tirzepatide
- Medication
- Consultation
- Shipping
- Supplies
Ratings Breakdown
| Category | Hers | IVY RX |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
Hers edges out IVY RX with a ClearScore of 79 vs 69. IVY RX is more affordable starting at $197/mo compared to $199/mo. For customer support, Hers rates higher (4.5/5). The best choice depends on your priorities, medication preferences, and budget.